Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

covid

  • Home
  •  
  • covid



  • Most Read
  • Latest Comments
  • AnteoTech locks in rapid COVID-19 mucus test and planned commercialisation
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • AnteoTech locks in rapid COVID-19 mucus test and planned commercialisation
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • AnteoTech locks in rapid COVID-19 mucus test and planned commercialisation
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • AnteoTech locks in rapid COVID-19 mucus test and planned commercialisation
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • AnteoTech locks in rapid COVID-19 mucus test and planned commercialisation
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • PainChek locks in performance data for FDA submission, aiming to be  first pain assessment app approved in US
    PainChek locks in performance data for FDA submission, aiming to be first pain assessment app approved in US
    • News

  • HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use
    HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use
    • News

  • dorsaVi secures $110k in contracts across mining, healthcare, and shipping sectors
    dorsaVi secures $110k in contracts across mining, healthcare, and shipping sectors
    • News

  • Compumedic hits record medtech diagnostics revenue with growth in US and China being targeted
    Compumedic hits record medtech diagnostics revenue with growth in US and China being targeted
    • News

  • TGA approves Control Bionic’s autonomous wheelchair for commercial sales after NDIS delays
    TGA approves Control Bionic’s autonomous wheelchair for commercial sales after NDIS delays
    • News

  • AnteoTech locks in rapid COVID-19 mucus test and planned commercialisation
    • News

    AnteoTech locks in rapid COVID-19 mucus test and planned commercialisation

    The rapidly evolving marketplace around a vaccine for COVID-19 and ongoing management has taken another turn in the right direction with biotech company AnteoTech (ASX: ADO) readying for clinical trials of their Antigen Rapid Test (ART) which can be done using just a person’s saliva sample.  The ART is another medical advancement in the market

    Read More
    Public
  • The New Criterion: No dead certainties in the listed funeral parlour game
    • Opinion

    The New Criterion: No dead certainties in the listed funeral parlour game

    One neat investment theory of the pandemic era is that the deathcare industry provides the perfect hedge against the human cost of the pestilence and the ensuing economic chaos. But as with having blind faith in gold as a safe harbour, the notion of funeral parlours as a defensive certainty should be dead buried and

    Read More
    Public
  • Savaged by COVID, Mosaic to permanently close 500 fashion stores
    • News

    Savaged by COVID, Mosaic to permanently close 500 fashion stores

    Retail in Australia has changed forever as a result of COVID-19 with Mosaic Brands (ASX: MOZ) the first large ASX-listed fashion retailer to announce mass closures of their retail network where up to 500 clothing stores will close permanently over the next two years.  The announcement to reduce their network of more than 1,333 stores,

    Read More
    Public
  • COVID pump fizzles as ASX scrutinise Holista Colltech, costly for new investors
    • News

    COVID pump fizzles as ASX scrutinise Holista Colltech, costly for new investors

    Amid the boom of retail investors entering opportunistic penny stocks capitalising on COVID, many are now under the watchful eye of ASX regulators after share price pumps led by business pivots into hygiene product supply such as hand sanitiser.  Just one of many to do so at the start of the pandemic, food production company

    Read More
    Public
  • QLD Government wants you visiting theme parks, issues Ardent $69.9m support
    • News

    QLD Government wants you visiting theme parks, issues Ardent $69.9m support

    With Queensland’s swift management of COVID-19, the Sunshine State is set to recover quicker than its southern neighbours and the State Government is aiming to restart its tourism industry via a $69.9m support package for Ardent Leisure (ASX: ALG) which will re-open Dreamworld and WhiteWater World in September. The financial assistance packages totaling $69.9 million

    Read More
    Public
  • 1
  • 2

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.